Alessandro Magini Selected Research

Alessandro Magini Research Topics

6	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2019 - 01/2011
3	Alzheimer Disease (Alzheimer's Disease) 01/2019 - 01/2010
2	Neuroblastoma 03/2019 - 05/2016
2	Tuberous Sclerosis (Bourneville's Disease) 05/2018 - 01/2017
2	Neoplasms (Cancer) 05/2018 - 03/2013
2	Inborn Genetic Diseases (Disease, Hereditary) 01/2017 - 08/2014
2	Sandhoff Disease (Sandhoff's Disease) 08/2014 - 02/2010
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2019
1	Central Nervous System Cavernous Hemangioma 01/2019
1	Carcinogenesis 05/2018
1	Neurologic Manifestations (Neurological Manifestations) 05/2018
1	Astrocytoma (Pilocytic Astrocytoma) 01/2017
1	Glycogen Storage Disease Type II (Pompe's Disease) 04/2015
1	Clinical Deterioration 04/2015
1	Lysosomal Storage Diseases (Lysosomal Storage Disease) 04/2015
1	GM2 Gangliosidoses (GM2 Gangliosidosis) 08/2014
1	Sphingolipidoses (Sphingolipidosis) 08/2014
1	Prostatic Neoplasms (Prostate Cancer) 06/2014
1	Starvation 04/2013
1	Infections 01/2012
1	Malaria 01/2012

6	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2010
3	TOR Serine-Threonine KinasesIBA 01/2019 - 05/2016
3	Hexosaminidases (Hexosaminidase)IBA 01/2015 - 06/2014
2	Glycoside Hydrolases (Endoglycosidases)IBA 03/2019 - 01/2015
2	LipidsIBA 03/2019 - 01/2015
2	Sirolimus (Rapamycin)FDA Link 01/2019 - 05/2016
2	MTOR InhibitorsIBA 01/2019 - 05/2016
2	trans-sodium crocetinate (crocetin)IBA 05/2018 - 01/2017
2	Mechanistic Target of Rapamycin Complex 1IBA 05/2018 - 01/2017
2	Biomarkers (Surrogate Marker)IBA 01/2015 - 03/2013
1	GlycosphingolipidsIBA 03/2019
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2019
1	Everolimus FDA Link 01/2019
1	Biological ProductsIBA 05/2016
1	EnzymesIBA 04/2015
1	poly(lactide) (polylactic acid)IBA 04/2015
1	GlycogenIBA 04/2015
1	alpha-Glucosidases (Acid Maltase)IBA 04/2015
1	AcidsIBA 04/2015
1	GalactosidasesIBA 01/2015
1	GangliosidesIBA 01/2015
1	Pyrimethamine (Daraprim)FDA Link 08/2014
1	G(M2) Ganglioside (Ganglioside GM2)IBA 08/2014
1	SphingolipidsIBA 08/2014
1	IsoenzymesIBA 06/2014
1	Messenger RNA (mRNA)IBA 06/2014
1	Hexosaminidase A (Hex A)IBA 06/2014
1	Transfer RNA (tRNA)IBA 04/2013
1	Amino Acids FDA Link 04/2013
1	beta-N-AcetylhexosaminidasesIBA 02/2010

2	Therapeutics 01/2019 - 08/2014